[11] [12] For weight management, NICE (TA875, TA664) recommends these medications for adults with a BMI of 35 kg/m or more (or 32.5 kg/m or more for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds) who have at least one weight-related comorbidity and are receiving care through specialist weight management services
Inadequate reporting of quality control procedures may lead to misinterpretation and prevent future meta-analysis of metabolomic findings (88)
NDTV reported that Sun Pharma launched Noveltreat for chronic weight management and Sematrinity for type 2 diabetes
RWD Life Sciences Inc.) was made daily into awake, unrestrained animals 5 minutes before behavioral testing with infusion needles remained in the guide cannula for 30 seconds after infusion
American Diabetes Association (2013) Economic costs of diabetes in the U.S
Our expert team is at the heart of our personalized care